Answers are grounded in this paper and cite their sources.
This analysis reveals CBD's effects on pain and anxiety in patients, highlighting the need for more research.
The reclassification of hemp’s legal status has resulted in a proliferation of retail cannabidiol (CBD) products. Preliminary research is emerging on CBD’s effect on pain, anxiety, depression, and addiction, but CBD is not a cure-all and there is an urgent need for more robust clinical trials. A pharmaceutical CBD product currently exists as an adjunct treatment for epilepsy disorders. However, several patients are experimenting with unregulated retail CBD products as an alternative treatment for a variety of medical conditions. The use of these retail CBD products is not without risks. Given the paucity of medical guidelines, this article provides an update for physicians and other healthcare practitioners on CBD and its potential side effects, drug interactions, and other safety concerns.
No takes yet. Share an insight, caveat, or question.
Kudrich et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: